AKTX
Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)
AKTX Filings
Filing Date
Form Description
Form Type
2026-03-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-04 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-04
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-04 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-02-02
Form DEF 14A - Other definitive proxy statements
Key Events
2026-02-02 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-30
Form EFFECT - Notice of Effectiveness
2026-01-30 ·
Form EFFECT - Notice of Effectiveness
2026-01-23
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-23 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-22
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-01-22 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-12-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
